REPORT ID 3021

United States Asthma Drugs Market Report 2017

Publish Date
12-Dec-17
Pages
102
Format
Electronic (PDF)

In this report, the United States Asthma Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Asthma Drugs in these regions, from 2012 to 2022 (forecast).

United States Asthma Drugs market competition by top manufacturers/players, with Asthma Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    GlaxoSmithKline
    Sanofi
    Roche & Novartis
    Teva
    Merck
    AstraZeneca
    Boehringer Ingelheim
    ...

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Long-term Control Medications
    Quick-relief Medications (Rescue Medications)
    Medications for Allergy-induced Asthma
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Asthma Drugs Market Report 2017
1 Asthma Drugs Overview
    1.1 Product Overview and Scope of Asthma Drugs
    1.2 Classification of Asthma Drugs by Product Category
        1.2.1 United States Asthma Drugs Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Asthma Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Long-term Control Medications
        1.2.4 Quick-relief Medications (Rescue Medications)
        1.2.5 Medications for Allergy-induced Asthma
    1.3 United States Asthma Drugs Market by Application/End Users
        1.3.1 United States Asthma Drugs Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 United States Asthma Drugs Market by Region
        1.4.1 United States Asthma Drugs Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Asthma Drugs Status and Prospect (2012-2022)
        1.4.3 Southwest Asthma Drugs Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Asthma Drugs Status and Prospect (2012-2022)
        1.4.5 New England Asthma Drugs Status and Prospect (2012-2022)
        1.4.6 The South Asthma Drugs Status and Prospect (2012-2022)
        1.4.7 The Midwest Asthma Drugs Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Asthma Drugs (2012-2022)
        1.5.1 United States Asthma Drugs Sales and Growth Rate (2012-2022)
        1.5.2 United States Asthma Drugs Revenue and Growth Rate (2012-2022)

2 United States Asthma Drugs Market Competition by Players/Suppliers
    2.1 United States Asthma Drugs Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Asthma Drugs Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Asthma Drugs Average Price by Players/Suppliers (2012-2017)
    2.4 United States Asthma Drugs Market Competitive Situation and Trends
        2.4.1 United States Asthma Drugs Market Concentration Rate
        2.4.2 United States Asthma Drugs Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Asthma Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 United States Asthma Drugs Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Asthma Drugs Sales and Market Share by Region (2012-2017)
    3.2 United States Asthma Drugs Revenue and Market Share by Region (2012-2017)
    3.3 United States Asthma Drugs Price by Region (2012-2017)

4 United States Asthma Drugs Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Asthma Drugs Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Asthma Drugs Revenue and Market Share by Type (2012-2017)
    4.3 United States Asthma Drugs Price by Type (2012-2017)
    4.4 United States Asthma Drugs Sales Growth Rate by Type (2012-2017)

5 United States Asthma Drugs Sales (Volume) by Application (2012-2017)
    5.1 United States Asthma Drugs Sales and Market Share by Application (2012-2017)
    5.2 United States Asthma Drugs Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Asthma Drugs Players/Suppliers Profiles and Sales Data
    6.1 GlaxoSmithKline
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Asthma Drugs Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GlaxoSmithKline Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi
        6.2.2 Asthma Drugs Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Roche & Novartis
        6.3.2 Asthma Drugs Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Roche & Novartis Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Teva
        6.4.2 Asthma Drugs Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Teva Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Merck
        6.5.2 Asthma Drugs Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Merck Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 AstraZeneca
        6.6.2 Asthma Drugs Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 AstraZeneca Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Boehringer Ingelheim
        6.7.2 Asthma Drugs Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Boehringer Ingelheim Asthma Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Asthma Drugs Manufacturing Cost Analysis
    7.1 Asthma Drugs Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Asthma Drugs

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Asthma Drugs Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Asthma Drugs Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Asthma Drugs Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Asthma Drugs Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Asthma Drugs Sales Volume Forecast by Type (2017-2022)
    11.3 United States Asthma Drugs Sales Volume Forecast by Application (2017-2022)
    11.4 United States Asthma Drugs Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer